U.S. allotting 85% less J&J vaccines to states next week, data shows




  • In US
  • 2021-04-08 06:39:07Z
  • By Reuters
 

(Reuters) - The U.S. government will allot nearly 85% less Johnson & Johnson COVID-19 vaccines to states next week, data from Centers for Disease Control and Prevention (CDC) showed.

Only 785,500 J&J doses will be allocated, compared to 4.95 million doses this week. The U.S. Department of Health and Human Services (HHS) and J&J did not immediately respond to requests, made outside regular hours, for comment on the drop in numbers.

A New York Times report last week said that workers at an Emergent BioSolutions facility in Baltimore, which produced both AstraZeneca Plc and J&J doses, mixed up ingredients of the two vaccines, ruining 15 million J&J doses.

However, the Baltimore facility has not yet been authorized by the U.S. Food and Drug Administration, and a federal health official told Reuters last week that none of the vaccine doses from the plant have been used in vaccination efforts so far.

J&J has reiterated that it expected to deliver 100 million doses to the government by the end of May.

According to the CDC data, California is the main recipient of the J&J vaccine, followed by Texas and Florida. The vaccine allocation for California is down by about 88%, with the state set to receive only a maximum of 67,600 doses next week.

A California health official told Reuters that the number will be down further in the week starting April 18, with only 22,400 doses of the J&J vaccine allocated to the state.

U.S. President Joe Biden on Tuesday moved up the COVID-19 vaccine eligibility target for all American adults to April 19.

(Reporting by Shubham Kalia and Aakriti Bhalla in Bengaluru; Editing by Simon Cameron-Moore)

COMMENTS

More Related News

J&J Covid Vaccine Reviewed by EU Regulator After Blood Clots
J&J Covid Vaccine Reviewed by EU Regulator After Blood Clots

(Bloomberg) -- The European Union's drug regulator has started a review to assess blood clots in people who received Johnson & Johnson's Covid-19...

White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators
White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators
  • US
  • 2021-04-09 16:17:40Z

Johnson & Johnson will ship relatively few COVID-19 shots around the United States until it receives regulatory clearance for a large vaccine plant in...

European regulators are watching J&J
European regulators are watching J&J's vaccine for unusual blood clots

The European Medicines Agency is investigating reports of clots in people who received J&J's vaccine. The shot has not yet been given out in Europe.

States are only getting 700,000 Johnson & Johnson vaccine doses next week, down from almost 5 million this week
States are only getting 700,000 Johnson & Johnson vaccine doses next week, down from almost 5 million this week

The distribution of the Johnson & Johnson COVID-19 vaccine has been varied for weeks, according to CDC data.

J&J set to begin India trial of its single-shot vaccine - report
J&J set to begin India trial of its single-shot vaccine - report
  • US
  • 2021-04-09 05:41:28Z

BENGALURU (Reuters) -Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country,...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US